Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$521M |
| 2 |
Nike
NKE
|
+$509M |
| 3 |
Micron Technology
MU
|
+$439M |
| 4 |
Super Micro Computer
SMCI
|
+$435M |
| 5 |
Broadcom
AVGO
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$5.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.89B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Microsoft
MSFT
|
+$1.07B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.38% |
| 2 | Consumer Discretionary | 1.03% |
| 3 | Financials | 0.75% |
| 4 | Healthcare | 0.67% |
| 5 | Communication Services | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXDX
11576
CALL
DELISTED
Accelerate Diagnostics
AXDX
| $22.9K | ﹤0.01% |
19,600
-200
| -1% | -$209 |
|
11577
Neuronetics
STIM
$229M
| $22.9K | ﹤0.01% |
12,718
-36,008
| -74% | -$104K |
|
11578
CALL
DarioHealth
DRIO
$68.9M
| $22.8K | ﹤0.01% |
960
-895
| -48% | -$25.4K |
|
11579
RAVE Restaurant Group
RAVE
$44.2M
| $22.6K | ﹤0.01% |
+11,431
| New | +$22.6K |
|
|
EVA
11580
DELISTED
Enviva Inc.
EVA
| $22.5K | ﹤0.01% |
52,428
-174,235
| -77% | -$87.6K |
|
11581
CALL
Milestone Pharmaceuticals
MIST
$147M
| $22.5K | ﹤0.01% |
+16,900
| New | +$27.2K |
|
|
ADAP
11582
PUT
DELISTED
Adaptimmune Therapeutics
ADAP
| $22.4K | ﹤0.01% |
23,100
+9,500
| +70% | +$10.4K |
|
|
MSPR
11583
DELISTED
MSP Recovery Inc
MSPR
| $22.3K | ﹤0.01% |
+278
| New | +$40.6K |
|
11584
CALL
Clene
CLNN
$59.7M
| $22.2K | ﹤0.01% |
3,085
+755
| +32% | +$5.65K |
|
|
SING
11585
DELISTED
SinglePoint Inc.
SING
| $22.2K | ﹤0.01% |
+1,335
| New | +$28.6K |
|
11586
Purple Innovation
PRPL
$20.6M
| $22.1K | ﹤0.01% |
850
-2,628
| -76% | -$92.4K |
|
11587
Focus Universal
FCUV
$6.83M
| $21.9K | ﹤0.01% |
+229
| New | +$26.5K |
|
|
AUGX
11588
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $21.9K | ﹤0.01% |
24,876
-238,311
| -91% | -$491K |
|
11589
Invivyd
IVVD
$266M
| $21.9K | ﹤0.01% |
19,886
-547,781
| -96% | -$1.21M |
|
11590
Fusion Fuel Green
HTOO
$14.3M
| $21.6K | ﹤0.01% |
701
-2,058
| -75% | -$87.7K |
|
11591
CALL
Urban One Class A
UONE
$22.4M
| $21.5K | ﹤0.01% |
+1,080
| New | +$23.4K |
|
11592
Retractable Technologies
RVP
$21.9M
| $21.4K | ﹤0.01% |
19,821
-11,015
| -36% | -$11.9K |
|
11593
Ascent Solar Technologies
ASTI
$30M
| $21.4K | ﹤0.01% |
+2,050
| New | +$28.7K |
|
11594
CareCloud
CCLD
$112M
| $21.3K | ﹤0.01% |
+11,117
| New | +$20.9K |
|
11595
PUT
Outdoor Holding Co
POWW
$252M
| $21.2K | ﹤0.01% |
12,600
-11,200
| -47% | -$27K |
|
11596
CALL
Aclaris Therapeutics
ACRS
$911M
| $21.1K | ﹤0.01% |
19,200
+5,700
| +42% | +$6.7K |
|
|
SLI
11597
Standard Lithium
SLI
$644M
| $21.1K | ﹤0.01% |
16,886
-32,375
| -66% | -$45K |
|
11598
Grove Collaborative
GROV
$41.6M
| $21.1K | ﹤0.01% |
11,917
-195,903
| -94% | -$314K |
|
11599
PUT
Red Cat Holdings
RCAT
$1.36B
| $21K | ﹤0.01% |
+18,300
| New | +$19.7K |
|
11600
MoneyHero
MNY
$37.9M
| $21K | ﹤0.01% |
+11,105
| New | +$23K |
|
Similar funds
Jeff Yass's Q2 2024 Portfolio in Review
As of Q2 2024, Jeff Yass held 13,638 positions worth $537B, down 6.7% from $576B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass withdrew a net $65.7B in Q2 2024, closing 1,726 positions and reducing 5,607 holdings. Its most notable exit was iShares MSCI USA Quality Factor ETF, an estimated $26.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in NextEra Energy 7.299% Corporate Units worth $127M.
- Jeff Yass's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M.
- Jeff Yass added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $521M increase.
- Jeff Yass's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $5.31B.
- Jeff Yass fully exited iShares MSCI USA Quality Factor ETF in Q2 2024, selling an estimated $26.2M.
- Jeff Yass's ten largest holdings make up 26% of its $537B portfolio in Q2 2024.
- Jeff Yass opened 1,591 new positions and closed 1,726 in Q2 2024.
- Jeff Yass's portfolio value fell 6.7% quarter-over-quarter to $537B.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.